Cannabigerol (Axim Biotechnologies)

N/A

Report date: 2025/12/30 16:02:50
NME

Base Information

Drug NameCannabigerol (Axim Biotechnologies)
Drug Alias Namecannabigerol
ClassificationSmall molecules
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor antagonistsCannabinoid CB1 receptor antagonistsAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2Serotonin 1a (5-HT1a) receptorCannabinoid CB1 receptor
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAxim Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAxim Biotechnologies Inc
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A